ค้นหาแบบเรียลไทม์
TopFind กำลังค้นหาผลลัพธ์ล่าสุดสำหรับการค้นหาของคุณ
เราตรวจสอบผลลัพธ์สด 44 รายการ สำหรับ amgevita adalimumab atto และคัดเหลือ 3 ตัวเลือก ที่น่าเปรียบเทียบก่อนที่สุด
ธีมที่เด่นที่สุดในรายการสั้นนี้คือ Prescription Medicine และ Biosimilar
แหล่งที่มา: Amgen (Thailand) Limited
คำอธิบาย
Amgevita is a biosimilar to Humira, containing the active substance adalimumab. It is used as a biologic therapy for inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and plaque psoriasis. Available in Thailand as a solution for injection in 20 mg/0.4 ml and 40 mg/0.8 ml pre-filled syringes or autoinjectors, it is classified as a Special Controlled Drug that requires professional medical supervision for prescription and dispensing.
เหมาะสำหรับ
Rheumatoid arthritis patients, Biosimilar drug preference, Chronic inflammation management และ Specialized biologic therapy
คะแนน
แหล่งที่มา: Amgen Inc.
คำอธิบาย
Amjevita is a prescription biosimilar to Humira (adalimumab) available in the United States. It is used to treat several inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. This citrate-free medication is delivered via the SureClick autoinjector or single-dose prefilled syringes in various dosages such as 40 mg and 20 mg.
เหมาะสำหรับ
Rheumatoid arthritis patients, US healthcare users, Humira biosimilar seekers และ Chronic inflammation management
คะแนน
แหล่งที่มา: Amgen Inc.
คำอธิบาย
Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes.
เหมาะสำหรับ
International patients, Uveitis treatment, Hidradenitis suppurativa care และ Ankylosing spondylitis patients
คะแนน
| เปรียบเทียบ | Amgevita (adalimumab-atto) | Amjevita (adalimumab-atto) | Amgevita (adalimumab) |
|---|---|---|---|
| แหล่งที่มา | Amgen (Thailand) Limited | Amgen Inc. | Amgen Inc. |
| คำอธิบาย | Amgevita is a biosimilar to Humira, containing the active substance adalimumab. It is used as a biologic therapy for inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and plaque psoriasis. Available in Thailand as a solution for injection in 20 mg/0.4 ml and 40 mg/0.8 ml pre-filled syringes or autoinjectors, it is classified as a Special Controlled Drug that requires professional medical supervision for prescription and dispensing. | Amjevita is a prescription biosimilar to Humira (adalimumab) available in the United States. It is used to treat several inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. This citrate-free medication is delivered via the SureClick autoinjector or single-dose prefilled syringes in various dosages such as 40 mg and 20 mg. | Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes. |
| เหมาะสำหรับ | Rheumatoid arthritis patients, Biosimilar drug preference, Chronic inflammation management และ Specialized biologic therapy | Rheumatoid arthritis patients, US healthcare users, Humira biosimilar seekers และ Chronic inflammation management | International patients, Uveitis treatment, Hidradenitis suppurativa care และ Ankylosing spondylitis patients |
| การดำเนินการ | |||
| คะแนน |
ถ้าคุณอยากเริ่มจากตัวเลือกที่สมดุลที่สุด ฉันแนะนำ:
"Amgevita (adalimumab-atto) จาก Amgen (Thailand) Limited."
ฉันเลือกสิ่งนี้เพราะ Amgevita is a reputable biosimilar offering from Amgen, providing a more accessible treatment option for patients requiring adalimumab with proven safety and efficacy profiles.